Peptide therapeutics is evolving as a
promising field over the past few years as a result of continuous
research and developments in the field for developing new and effective
drugs. New delivery techniques and manufacturing technologies coupled
with intensified research and development programs is resulting in the
approval of new peptide based drugs.
Peptide therapeutics is the best
option in recombinant medicines due to their low toxicity, high
specificity, and much lower molecular weight which makes it easier to
prepare dosage plans for patients. Improvements in manufacturing process
and delivery systems are triggering the growth of this industry.
Many large pharmaceutical companies
are funding research and developments in this field which is further
creating new opportunities for development of this industry. Emerging
sectors of this industry like anti-infectives, vaccines, and central
nervous system targeting peptides are well set for development of a new
class of drugs.
Read More: Peptide Therapeutics Market
Market Segmentation
Segmentation Based on Product
- Anticancer Peptides
- Receptor Interacting Peptides
- Anti-Microbial Peptides
- Antiviral
Peptide therapeutics market analyzes
this market based on its market segments and geographies covered. Major
geographies analyzed under this research report include
- North America
- Europe
- Asia Pacific
- Rest of the World
This report includes comprehensive
analysis of current trends in market, industry growth drivers, factors
affecting market growth, market structure, and industry projections for
upcoming years. This report also includes detailed analysis of
technological improvements in the field, Porter’s five force model
analysis, and complete company profiles of top industry players.
The report provides review of micro
and macro factors significant with respect to new entrants and existing
market players with value chain analysis.
Major Players
Some of the major players dominating
this market are Affymax, Amylin Pharmaceutical Inc, AM-Pharma, Angstrom
Pharmaceuticals, Argolyn Biosciences, Demegen, Enanta Pharmaceuticals,
Helix Biomedix, Jerini Pharmaceuticals, PPL Therapeutics, ProCyte
Corporation, Targeted Molecule Corporation, Theratechnologies, Zengen
Inc, and others.
Reasons for Buying this Report
- This research report provides overview of major market forces driving and restraining market growth
- It provides clear understanding of changing competitive dynamics and keeps you ahead of competitors
- Report provides technological growth map over time and explains its impact on market
- It helps in making informed business decisions by making in-depth analysis of market
- It provides distinctive graphics and exemplified SWOT analysis of major industry segments
- Report provides detailed analysis of major competitors and their strategies
- It also provides up-to-date analysis of latest trends in market and helps you stay updated with recent technological improvements.
http://www.transparencymarketresearch.com/peptide-therapeutics-market.html
Many companies within the industry were surveyed to obtain data for this study. Included were manufacturers and end users of pharmaceuticals through contract manufacturing and research. Data were gathered from various industry sources. BCC spoke with officials and physicians within the industry, and consulted newsletters, company literature, product literature, and a host of technical articles, journals, indexes, and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade, and government sources.
ReplyDeleteMarket Report